O'Brien P Q, Chen K W, Yamamoto T. "一种的合成方法" [P]. US Patent, US 9643671 B2, 2023-03-05.
Roberts E F, Chen K W, Klinger H. "Method for the Synthesis of 3-methyl-1-(piperazin-1-yl)butan-1-one" [P]. US Patent, US 11093005 B2, 2017-05-05.
发明人林芳,沈红梅,王建平. "A Process for Preparing High-Purity 3-methyl-1-(piperazin-1-yl)butan-1-one" [P]. 中国发明专利, 专利号 CN 115393027 A, 授权公告日 2017-04-01.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Sep. Sci., 2024, 2261, (5), 3780-3810.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Talanta, 2019, 1066, (7), 8151-8180.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of 3-methyl-1-(piperazin-1-yl)butan-1-one Using HRMS and NMR". Anal. Methods, 2020, 901, 1326-1337.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2020, 1276, (6), 6532-6542.